System for delivering microwave ablation to subcutaneous tumors in small-animals under high-field MRI thermometry guidance
Jazyk angličtina Země Anglie, Velká Británie Médium print
Typ dokumentu časopisecké články, práce podpořená grantem, Research Support, N.I.H., Extramural
Grantová podpora
R01 EB028848
NIBIB NIH HHS - United States
PubMed
35435078
PubMed Central
PMC9717487
DOI
10.1080/02656736.2022.2061727
Knihovny.cz E-zdroje
- Klíčová slova
- MRI thermometry, Small-animal ablation system, magnetic resonance imaging, microwave ablation,
- MeSH
- magnetická rezonanční tomografie metody MeSH
- mikrovlny terapeutické užití MeSH
- myši nahé MeSH
- myši MeSH
- nádory * diagnostické zobrazování chirurgie MeSH
- termometrie * MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
PURPOSE: Bio-effects following thermal treatments are a function of the achieved temperature profile in tissue, which can be estimated across tumor volumes with real-time MRI thermometry (MRIT). Here, we report on expansion of a previously developed small-animal microwave hyperthermia system integrated with MRIT for delivering thermal ablation to subcutaneously implanted tumors in mice. METHODS: Computational models were employed to assess suitability of the 2.45 GHz microwave applicators for delivering ablation to subcutaneous tumor targets in mice. Phantoms and ex-vivo tissues were heated to temperatures in the range 47-67 °C with custom-made microwave applicators for validating MRIT with the proton resonance frequency shift method against fiberoptic thermometry. HAC15 tumors implanted in nude mice (n = 6) were ablated in vivo and monitored with MRIT in multiple planes. One day post ablation, animals were euthanized, and excised tumors were processed for viability assessment. RESULTS: Average absolute error between temperatures from fiberoptic sensors and MRIT was 0.6 °C across all ex-vivo ablations. During in-vivo experiments, tumors with volumes ranging between 5.4-35.9 mm3 (mean 14.2 mm3) were ablated (duration: 103-150 s) to achieve 55 °C at the tumor boundary. Thermal doses ≥240 CEM43 were achieved across 90.7-98.0% of tumor volumes for four cases. Ablations were incomplete for remaining cases, attributed to motion-affected thermometry. Thermal dose-based ablative tumor coverage agreed with viability assessment of excised tumors. CONCLUSIONS: We have developed a system for delivering microwave ablation to subcutaneous tumors in small animals under MRIT guidance and demonstrated its performance in-vivo.
Department of Anatomy and Physiology Kansas State University Manhattan KS USA
Department of Cancer Biology University of Kansas Medical Center Kansas City KS USA
Department of Chemistry Kansas State University Manhattan KS USA
Department of Circuit Theory Czech Technical University Prague Prague Czech Republic
Department of Electrical and Computer Engineering Kansas State University Manhattan KS USA
Zobrazit více v PubMed
Ghaghada KB, Badea CT, Karumbaiah L, et al. Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging. Acad Radiol 2011; 18(1):20–30. PubMed PMC
Kumar S, Arbab AS, Jain R, et al. Development of a novel animal model to differentiate radiation necrosis from tumor recurrence. J Neurooncol 2012;108(3):411–420. PubMed PMC
Weizsaecker M, Deen DF, Rosenblum ML, et al. The 9L rat brain tumor: description and application of an animal model. J Neurol 1981;224(3):183–192. PubMed
Lee KH, Liapi E, Vossen JA, et al. Distribution of iron oxide–containing embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: evaluation with MR imaging and implication for therapy. J Vasc Interv Radiol 2008; 19(10):1490–1496. PubMed PMC
Head HW, Dodd GD, Bao A III, et al. Combination radiofrequency ablation and intravenous radiolabeled liposomal doxorubicin: imaging and quantification of increased drug delivery to tumors. Radiology 2010;255(2):405–414. PubMed PMC
Ahmed M, Brace CL, Lee FT Jr, et al. Principles of and advances in percutaneous ablation. Radiology 2011;258(2):351–369. PubMed PMC
Manthe RL, Foy SP, Krishnamurthy N, et al. Tumor ablation and nanotechnology. Mol Pharm 2010;7(6):1880–1898. PubMed PMC
May JP, Li SD. Hyperthermia-induced drug targeting. Expert Opin Drug Deliv 2013;10(4):511–527. PubMed
Rao W, Deng Z-S, Liu J. A review of hyperthermia combined with radiotherapy/chemotherapy on malignant tumors. Crit Rev Biomed Eng 2010;38(1):101–116. PubMed
Paulides MM, Trefna HD, Curto S, et al. Recent technological advancements in radiofrequency-andmicrowave-mediated hyperthermia for enhancing drug delivery. Adv Drug Deliv Rev 2020; 163–164:3–18. PubMed
Pearce JA. Models for thermal damage in tissues: processes and applications. Crit Rev Biomed Eng 2010;38(1):1–20. PubMed
Hall SK, Ooi EH, Payne SJ. Cell death, perfusion and electrical parameters are critical in models of hepatic radiofrequency ablation. Int J Hyperthermia 2015;31(5):538–550. PubMed PMC
Sebek J, Albin N, Bortel R, et al. Sensitivity of microwave ablation models to tissue biophysical properties: a first step toward probabilistic modeling and treatment planning. Med Phys 2016;43(5): 2649–2661. PubMed
Haemmerich D, Schutt DJ. Effects of micro-and macro-vascular perfusion during radiofrequency tumor ablation. In: Energy-Based treatment of tissue and assessment Vol. 7181. Bellingham (WA): International Society for Optics and Photonics; 2009. 71810R.
Curto S, Faridi P, Shrestha TB, et al. An integrated platform for small-animal hyperthermia investigations under ultra-high-field MRI guidance. Int J Hyperthermia 2018;34(4):341–351. PubMed
Amabile C, Ahmed M, Solbiati L, et al. Microwave ablation of primary and secondary liver tumours: ex vivo, in vivo, and clinical characterisation. Int J Hyperthermia 2017;33(1):34–42. PubMed
Chen Z, Shen S, Peng B, et al. Intratumoural GM-CSF microspheres and CTLA-4 blockade enhance the antitumour immunity induced by thermal ablation in a subcutaneous murine hepatoma model. Int J Hyperthermia 2009;25(5):374–382. PubMed
Yu Z, Geng J, Zhang M, et al. Treatment of osteosarcoma with microwave thermal ablation to induce immunogenic cell death. Oncotarget 2014;5(15):6526–6539. PubMed PMC
Hohenforst-Schmidt W, Zarogoulidis P, Stopek J, et al. Enhancement of intratumoral chemotherapy with cisplatin with or without microwave ablation and lipiodol. Future concept for local treatment in lung cancer. J Cancer 2015;6(3):218–226. PubMed PMC
Duan X, Wang M, Han X, et al. Combined use of microwave ablation and cell immunotherapy induces nonspecific immunity of hepatocellular carcinoma model mice. Cell Cycle 2020; 19(24): 3595–3607. PubMed PMC
Zhong X, Zhou Y, Cao Y, et al. Enhanced antitumor efficacy through microwave ablation combined with a dendritic cellderived exosome vaccine in hepatocellular carcinoma. Int J Hyperthermia 2020;37(1):1210–1218. PubMed
Yu M, Pan H, Che N, et al. Microwave ablation of primary breast cancer inhibits metastatic progression in model mice via activation of natural killer cells. Cell Mol Immunol 2021;18(9): 2153–2164. PubMed PMC
Ahmad F, Gravante G, Bhardwaj N, et al. Renal effects of microwave ablation compared with radiofrequency, cryotherapy and surgical resection at different volumes of the liver treated. Liver Int 2010;30(9):1305–1314. PubMed
Zhou H, Sun Y, Wang Q, et al. N-acetylcysteine alleviates liver injury by suppressing macrophage-mediated inflammatory response post microwave ablation. Int Immunopharmacol 2020; 85:106580. PubMed
Vogl TJ, Qian J, Tran A, et al. Study on the effect of chemoembolization combined with microwave ablation for the treatment of hepatocellular carcinoma in rats. Diagn Interv Radiol 2017;23(2): 150–155. PubMed PMC
Chen Y, Bei J, Liu M, et al. Sublethal heat stress-induced OGlcNAcylation coordinates the Warburg effect to promote hepatocellular carcinoma recurrence and metastasis after thermal ablation. Cancer Lett 2021;518:23–34. PubMed
Yoon J, Cho J, Kim N, et al. High-frequency microwave ablation method for enhanced cancer treatment with minimized collateral damage. Int J Cancer 2011;129(8):1970–1978. PubMed
Moon TJ, Brace CL. Design of a dual slot antenna for small animal microwave ablation studies. Annu Int Conf IEEE Eng Med Biol Soc 2016;2016:348–351. PubMed
Qi X, Li G, Liu D, et al. Development of a radiofrequency ablation platform in a clinically relevant murine model of hepatocellular cancer. Cancer Biol Ther 2015;16(12):1812–1819. PubMed PMC
Lee JE, Diederich CJ, Bok R, et al. Assessing high-intensity focused ultrasound treatment of prostate cancer with hyperpolarized 13 C dual-agent imaging of metabolism and perfusion. NMR Biomed 2019;32(10):e3962. PubMed PMC
Faridi P, Bossmann SH, Prakash P. Simulation-based design and characterization of a microwave applicator for MR-guided hyperthermia experimental studies in small animals. Biomed Phys Eng Express 2019;6(1):015001. PubMed PMC
Faridi P, Keselman P, Fallahi H, et al. Experimental assessment of microwave ablation computational modeling with MR thermometry. Med Phys 2020;47(9):3777–3788. PubMed PMC
Priester MI, Curto S, Seynhaeve ALB, et al. Preclinical studies in small animals for advanced drug delivery using hyperthermia and intravital microscopy. Cancers 2021;13(20):5146. PubMed PMC
Zhu M, Sun Z, Ng CK. Image-guided thermal ablation with MRbased thermometry. Quant Imaging Med Surg 2017;7(3):356–368. PubMed PMC
Rieke VM. Thermometry. Intervention Magnetic Resonance Imaging 2011. p. 271–288. PubMed
IT’IS Foundation. Tissue properties database V4.0 2018.
Fallahi H, Sebek J, Prakash P. Broadband dielectric properties of ex vivo bovine liver tissue characterized at ablative temperatures. IEEE Trans Biomed Eng 2021;68(1):90–98. PubMed PMC
Durick NA, Laeseke PF, Broderick LS, et al. Microwave ablation with triaxial antennas tuned for lung: results in an in vivo porcine model. Radiology 2008;247(1):80–87. PubMed
Yung JP, Shetty A, Elliott A, et al. Quantitative comparison of thermal dose models in normal canine brain. Med Phys 2010; 37(10):5313–5321. PubMed PMC